Oceanpine Healthcare Fund

Oceanpine Healthcare Fund is a Chinese healthcare venture capital firm based in Beijing, China, investing in biotechnology, medical devices, innovative drug discovery / novel therapeutics, genome sequencing, in-vitro diagnostics (IVD), and adjacent healthcare-technology themes. The firm is part of the broader Oceanpine Capital group founded by Richard Du (He Tao) and other Chinese healthcare-investment principals, with a thesis of investing in Chinese domestic healthcare innovation and U.S.-China cross-border healthcare opportunities. Oceanpine Capital has raised multiple USD- and RMB-denominated institutional funds with aggregate AUM in the USD several-hundred-million to low-billion range. The firm operates within China's active healthcare / biotech investment ecosystem alongside firms such as Lilly Asia Ventures, Qiming Venture Partners Healthcare, 6 Dimensions Capital, and Qiming Venture Partners' healthcare practice. Detailed current-fund AUM, fund-vintage disclosures, and comprehensive portfolio-company disclosures are partially documented in mainstream English-language financial-industry databases. The row should be noted as Active.